7 | Pharmaceutical PreparationsIBA
01/2022
-
12/2012 |
4 | GemcitabineFDA Link
01/2022
-
12/2017 |
4 | LigandsIBA
01/2022
-
07/2011 |
3 | 6- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA
10/2020
-
09/2011 |
3 | Biomarkers (Surrogate Marker)IBA
09/2020
-
12/2015 |
3 | Phosphotransferases (Kinase)IBA
02/2011
-
11/2007 |
2 | Capecitabine (Xeloda)FDA Link
01/2022
-
01/2020 |
2 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2021
-
12/2020 |
2 | ProteomeIBA
01/2021
-
09/2011 |
2 | Proteins (Proteins, Gene)FDA Link
01/2021
-
09/2011 |
2 | Liposomes (Liposome)IBA
11/2013
-
02/2011 |
2 | Dasatinib (BMS 354825)FDA Link
12/2012
-
02/2012 |
2 | AndrogensIBA
10/2009
-
01/2003 |
2 | 2'-fluoro-5-ethylarabinosyluracil (FEAU)IBA
08/2009
-
04/2008 |
2 | LuciferasesIBA
08/2009
-
07/2008 |
1 | Indicators and Reagents (Reagents)IBA
01/2022 |
1 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2022 |
1 | N- (2- amino- 3- (4- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N',N',N'',N''- pentaacetic acidIBA
01/2022 |
1 | Pentetic Acid (DTPA)FDA LinkGeneric
01/2022 |
1 | Androgen Receptors (Androgen Receptor)IBA
01/2022 |
1 | Immune Checkpoint InhibitorsIBA
10/2021 |
1 | 1- (2'- deoxy- 2'- fluoro- arabinofuranosyl)cytosineIBA
01/2021 |
1 | PEGPH20IBA
01/2021 |
1 | Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
01/2021 |
1 | AntibodiesIBA
01/2021 |
1 | Mitogen-Activated Protein KinasesIBA
12/2020 |
1 | trametinibIBA
12/2020 |
1 | Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
12/2020 |
1 | N 30IBA
10/2020 |
1 | Fluorouracil (Carac)FDA LinkGeneric
01/2020 |
1 | 130-nm albumin-bound paclitaxelIBA
01/2020 |
1 | Adenosine Triphosphate (ATP)IBA
01/2020 |
1 | CytosineIBA
12/2017 |
1 | IodidesIBA
11/2016 |
1 | Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2015 |
1 | pexidartinibIBA
05/2014 |
1 | Imatinib Mesylate (Gleevec)FDA Link
05/2014 |
1 | Peptides (Polypeptides)IBA
11/2013 |
1 | CyclooctanesIBA
11/2013 |
1 | ProdrugsIBA
04/2013 |
1 | EnzymesIBA
04/2013 |
1 | Laminin ReceptorsIBA
04/2013 |
1 | MicellesIBA
12/2012 |
1 | Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
12/2012 |
1 | FluorineIBA
12/2012 |
1 | Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
12/2012 |
1 | Biological ProductsIBA
12/2012 |
1 | Oncogene Proteins (Oncogene Protein)IBA
09/2011 |
1 | LipidsIBA
02/2011 |
1 | ErbB Receptors (EGF Receptor)IBA
02/2011 |
1 | 2- (4- iodophenylamino)pyrido(2,3- d)pyrimidin- 7- oneIBA
01/2010 |
1 | 2-18F-fluoropropionic acidIBA
10/2009 |
1 | AcidsIBA
10/2009 |
1 | Firefly LuciferasesIBA
08/2009 |
1 | Transforming Growth Factor beta (TGF-beta)IBA
08/2009 |
1 | AntigensIBA
07/2008 |
1 | Renilla LuciferasesIBA
07/2008 |
1 | GuanineIBA
05/2008 |
1 | 2'- fluoro- 2'- deoxy- 5- fluoroethyl- 1- beta- D- arabinofuranosyl uracilIBA
04/2008 |
1 | Tyrosine (L-Tyrosine)FDA Link
11/2007 |
1 | GoldIBA
01/2003 |
1 | tetrakis((trishydroxymethyl)phosphine)gold(I)IBA
01/2003 |